Research Article

The Prognostic Significance of Hsp70 in Patients with Colorectal Cancer Patients: A PRISMA-Compliant Meta-Analysis

Table 1

Main characteristics of the 11 studies in the meta-analysis.

StudyCountryYearSampleStudy designSizesCut-off valueGender (female/male)Follow-up time (month)Tumor stage (I/II/III/IV)OutcomeMethodNOS

Dundas, S. et al.Britain2005CRCR23125%NA0-120NAOSIHC7
Graf, L. et al.Hungary2018CRCR23220%112/1200-60NAOSIHC7
Jubran, R. et al.Hungary2017CRCR227NR121/1060-6030/40/60/97OSIHC8
Kocsis, J. et al.Hungary2009CRCR178NR89/8833 (24-44)25/26/60/67OSIHC9
Kocsis, J. et al.Hungary2010CRCR254NRNA33.0 (23.5–43.5)80/60/110/4OSIHC8
Lazaris, A. et al.Greece1997CRCR12825%NA44.76 (0-222.36)NAOSIHC9
Jogi, A. et al.Sweden2009CRCR19625%NA0-60NAOSIHC8
Shotar, A. et al.Jordan2005CRCR21520%112/1036.88 (0.64-17.05)40/32/79/64OSIHC8
Sun, X. et al.Sweden1997CRCR25620%122/1340-156NAOSIHC7
Kim, J. et al.Korea2014CRCR16725%NA29 (0-120)NADFSIHC9
Oh, H. et al.Korea2017CRCR185NR90/9551.1 (3.1-57.1)NADFSIHC9

Abbreviation: CRC: colorectal cancer; R: retrospective analysis; NR: not report; OS: overall survival; DFS: disease-free survival; IHC: immunohistochemistry; NA: not available; NOS: Newcastle-Ottawa Scale.